Auspex Diagnostics offers a groundbreaking colorectal cancer test designed to assist stage II and III patients and their doctors in personalizing treatment based on individual tumor genetics. By analyzing unique tumor gene expression data and comparing it to a proprietary database, the test assesses the risk of cancer recurrence post-surgery and evaluates the efficacy of chemotherapy options. With a strong predictive capability, it categorizes patients into low and high-risk groups, guiding decisions on adjuvant chemotherapy.
選單